India’s bioeconomy surged from $10 billion in 2014 to over $195 billion in 2025, contributing nearly 5% to the national GDP. Speaking at the 14th Foundation Day of the Biotechnology Industry Research Assistance Council (BIRAC), the Union Minister Dr. Jitendra Singh highlighted a 17–18% annual growth rate, positioning India as a global biotechnology hub.
The sector's expansion is driven by the BioE3 Policy (Biotechnology for Economy, Environment, and Employment) and a robust network of over 11,800 startups. With the release of the India Bioeconomy Report (IBER) 2026, the government reaffirmed its target to reach a $300 billion bioeconomy by 2030, supported by a new ₹1 lakh crore Research, Development, and Innovation (RDI) Fund.
Key Drivers of the $195 Billion Bioeconomy
Massive Growth Trajectory: The sector has more than doubled in size since 2020, achieving a CAGR of nearly 18% to reach $195.3 billion in 2025.
Startup Powerhouse: Over 11,800 biotech startups are currently operational, with a increasing focus on talent from tier-2 and tier-3 cities.
BioE3 Policy Framework: A strategic push for sustainable biomanufacturing in high-tech areas like precision biotherapeutics, smart proteins, and carbon capture.
Infrastructure Innovation: BIRAC is establishing shared infrastructure including biofoundries, Bio-AI hubs, and advanced biomanufacturing platforms.
Financial Catalyst: The ₹1 lakh crore RDI Fund is being utilized to channel long-term investment into deep-tech projects ready for market translation.
Economic Contribution: The bioeconomy now accounts for 4.8% of India's GDP, impacting healthcare, agriculture, and climate solutions.
What is Biotechnology Industry Research Assistance Council (BIRAC)? The BIRAC is a specialised, not-for-profit Public Sector Enterprise set up by the Department of Biotechnology (DBT) to act as an interface agency between academia and industry. Its primary mission is to nurture and scale the Indian biotech ecosystem by providing strategic funding, mentorship, and access to shared infrastructure like biofoundries and Bio-AI hubs. Since its inception, BIRAC has been instrumental in transforming laboratory research into market-ready solutions. It ensures that innovative breakthroughs in healthcare, agriculture, and sustainable manufacturing contribute directly to India's goal of a $300 billion bioeconomy by 2030.
What is the "BioE3 Policy"? BioE3 stands for Biotechnology for Economy, Environment, and Employment. It is a comprehensive policy framework designed to transition India toward high-performance, sustainable biomanufacturing. The policy plays a role in addressing global challenges by promoting climate-resilient agriculture and bio-based chemicals while simultaneously generating large-scale employment. It is supported by the goal of building specialized hubs, such as Bio-AI centers, which integrate artificial intelligence with biological data to accelerate the development of affordable healthcare and sustainable technologies. This shift from traditional manufacturing to bio-based production reflects growth in India’s commitment to a circular, self-reliant economy.
Policy Relevance: Scaling Innovation for a Developed India
Scaling Deep-Tech Investment: The allocation of the RDI Fund to biotechnology ventures reflects growth in the government's strategy to bridge the gap between laboratory research and commercial scale-up.
Internalising Sustainable Manufacturing: By prioritizing carbon capture and bio-based chemicals, the BioE3 policy plays a role in aligning industrial growth with India’s net-zero climate commitments.
Bypassing Import Dependencies: Strengthening domestic biofoundries is supported by the need to produce critical biotherapeutics and smart proteins locally, ensuring national health and food security.
Supporting Inclusive Innovation: Focused initiatives for women entrepreneurs and researchers in smaller cities contribute to democratizing the biotech ecosystem and building a nationwide culture of innovation.
Relevant Question for Policy Stakeholders: How will BIRAC ensure that the newly established Bio-AI hubs are integrated with existing academic research to prevent duplication of efforts?
Follow the Full News Here: India’s Bioeconomy surges to $195 billion in a decade
